Table 2.
Laboratory findings of before and after eculizumab therapy
| Pretreatment | After eculizumab therapy | P | |
|---|---|---|---|
| Hemoglobin level, mean, (range) g/dL | 8.75±2.13 (3.6-15) | 10.83±2.46 (4.7-15.8) | P < 0.001 |
| MCV | 95.53±10.46 (77.2-123) | 99. 87±10.42 (70.9-130) | |
| Leukocyte count, mean, (range) ×109/L | 4.56±2.9 (0.8-27.2) | 4.84±1.9 (1-11.2) | |
| Neutrophil count, mean, (range) ×109/L | 2.4±1.6 (0.18-8.2) | 2.7±1.4 (0.22-8.4) | |
| Platelet count, mean, (range) ×109/L | 123±126 (8-727) | 143±102 (7-704) | |
| LDH (range) IU/L | 1234 (136-10314) | 409 (146-4087) | P < 0.001 |
| Total billirubin level, mean, (range) | 1.59±1.3 (0.19-11.07) | 1.63±1.2 (0.19-7.6) |
Abbreviations: MCV (mean corpuscular volume), LDH (lactate dehydrogenase).